Jing You Selected Research

Analgesia

8/2015	Discharge Readiness after Tricompartment Knee Arthroplasty: Adductor Canal versus Femoral Continuous Nerve Blocks-A Dual-center, Randomized Trial.
1/2015	Chronic intermittent hypoxia is independently associated with reduced postoperative opioid consumption in bariatric patients suffering from sleep-disordered breathing.
8/2013	The analgesic efficacy of subcostal transversus abdominis plane block compared with thoracic epidural analgesia and intravenous opioid analgesia after radical gastrectomy.
3/2011	Combined versus sequential injection of mepivacaine and ropivacaine for supraclavicular nerve blocks.
7/2010	Association between epidural analgesia and cancer recurrence after colorectal cancer surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing You Research Topics

Disease

10	Pain (Aches) 10/2019 - 07/2010
9	Neoplasms (Cancer) 12/2023 - 07/2010
9	Infections 01/2023 - 02/2008
4	Chronic Hepatitis B 12/2023 - 02/2005
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2023 - 01/2020
4	Lung Neoplasms (Lung Cancer) 03/2023 - 01/2020
4	Fibrosis (Cirrhosis) 01/2022 - 02/2012
3	Adenocarcinoma of Lung 07/2023 - 01/2021
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2018
3	Pneumonia (Pneumonitis) 01/2018 - 04/2011
3	Obesity 01/2017 - 02/2012
3	Hepatitis B 11/2006 - 04/2003
2	Wounds and Injuries (Trauma) 02/2024 - 10/2012
2	Carcinoma (Carcinomatosis) 05/2023 - 11/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2023 - 09/2019
2	COVID-19 01/2023 - 01/2021
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 05/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2019
2	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2010
2	Stroke (Strokes) 03/2019 - 01/2017
2	Breast Neoplasms (Breast Cancer) 09/2017 - 01/2012
2	Postoperative Pain 08/2017 - 07/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 01/2017
2	Pulmonary Embolism 01/2017 - 08/2014
2	Non-alcoholic Fatty Liver Disease 01/2017 - 02/2012
2	Myocardial Infarction 01/2017 - 08/2014
2	Fatty Liver 01/2017 - 02/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017 - 08/2014
2	Hypoxia (Hypoxemia) 01/2015 - 01/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2023
1	Anxiety Disorders (Anxiety Disorder) 09/2023
1	Tertiary Lymphoid Structures 03/2023
1	Chronic Renal Insufficiency 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2017
7	Opioid Analgesics (Opioids)IBA 08/2017 - 03/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2005
5	Hepatitis B e AntigensIBA 07/2009 - 02/2005
3	CollagenIBA 02/2024 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 06/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2017
3	Therapeutic UsesIBA 01/2023 - 01/2021
3	Caspase 3 (Caspase-3)IBA 01/2023 - 05/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Vitamin D FDA LinkGeneric 07/2015 - 01/2013
2	Environmental Pollutants (Pollutants, Environmental)IBA 09/2023 - 08/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2023 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 03/2023 - 01/2022
2	CytokinesIBA 01/2023 - 01/2023
2	VaccinesIBA 01/2023 - 01/2021
2	NeonicotinoidsIBA 01/2022 - 01/2022
2	Hormones (Hormone)IBA 01/2022 - 07/2006
2	acetamipridIBA 01/2022 - 03/2019
2	HydrogenIBA 01/2021 - 05/2017
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 05/2017
2	SteroidsIBA 08/2019 - 11/2015
2	Serum AlbuminIBA 01/2019 - 01/2017
2	CystathionineIBA 09/2017 - 05/2017
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 07/2011
2	Morphine (MS Contin)FDA LinkGeneric 07/2015 - 08/2013
2	Interferon-alpha (Interferon Alfa)IBA 11/2006 - 02/2005
2	ThymosinIBA 11/2006 - 02/2005
1	EmulsionsIBA 02/2024
1	HydrogelsIBA 02/2024
1	Cytidine DeaminaseIBA 12/2023
1	Iridium-192IBA 10/2023
1	6-methyladenineIBA 10/2023
1	Air Pollutants (Pollutants, Air)IBA 09/2023
1	Circular RNAIBA 07/2023
1	Histocompatibility Antigens Class IIIBA 03/2023
1	LigandsIBA 03/2023
1	ErbB Receptors (EGF Receptor)IBA 03/2023
1	Immune Checkpoint InhibitorsIBA 03/2023
1	AntioxidantsIBA 01/2023
1	Nonprescription Drugs (Patent Medicines)IBA 01/2023
1	shenkangIBA 01/2023
1	Oxidants (Oxidizing Agents)IBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2023
1	NucleotidesIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023

Therapy/Procedure

10	Radiotherapy 05/2023 - 01/2017
6	Therapeutics 01/2023 - 02/2005
5	Analgesia 08/2015 - 07/2010
4	Anesthesia 01/2021 - 09/2013
4	Bariatric Surgery 07/2015 - 02/2012
3	Immunotherapy 12/2023 - 03/2023
3	Drug Therapy (Chemotherapy) 11/2019 - 01/2017
2	Brachytherapy 10/2023 - 11/2020
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023 - 11/2019
2	Chemoradiotherapy 01/2023 - 01/2022
2	Length of Stay 12/2016 - 04/2012
2	Liver Transplantation 08/2013 - 09/2011